IL3RA and neoplasm: A previous study demonstrated that IL-3Rα blockade on TEC, by an anti-IL-3Rα36, changed the miR-EV cargo and had striking effects on tumor vessel formation31, suggesting that reprogramming TEC-EVs may also be instrumental in tumor targeting.